Biden gives U.S. intelligence community 90 days to report on COVID-19 origin theories

President Biden on Wednesday issued a statement on the investigation of the origins of the coronavirus that sparked the COVID-19 pandemic, calling on the U.S. intelligence community to "redouble their efforts to collect and analyze information" and "report back to me in 90 days."
Initially, the virus was believed to have jumped to humans naturally from an animal host. The scientific community still widely subscribes to this theory, but as time has gone on without any definitive answers, the notion that the virus began to spread after a laboratory accident (the theory is not to be confused with claims that the virus was a deliberately released bioweapon) in Wuhan, China, is now considered more plausible by prominent figures, or at least plausible enough that they believe it warrants a deeper look than investigators from the Chinese government and the World Health Organization have given it so far.
Indeed, Biden's statement suggests the intelligence community's only consensus, at the moment, is that there isn't "sufficient evidence" to pin down one scenario as the most likely.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Tim is a staff writer at The Week and has contributed to Bedford and Bowery and The New York Transatlantic. He is a graduate of Occidental College and NYU's journalism school. Tim enjoys writing about baseball, Europe, and extinct megafauna. He lives in New York City.
-
Apple bows to Trump administration pressure over ICE tracking apps
In the Spotlight It’s the latest company to capitulate to Trump’s demands
-
Can TrumpRx really lower drug prices?
Today’s Big Question Pfizer’s deal with Trump sent drugmaker stocks higher
-
‘Every argument has a rational, emotional, and rhetorical component’
Instant Opinion Opinion, comment and editorials of the day
-
FDA OKs generic abortion pill, riling the right
Speed Read The drug in question is a generic version of mifepristone, used to carry out two-thirds of US abortions
-
The new Stratus Covid strain – and why it’s on the rise
The Explainer ‘No evidence’ new variant is more dangerous or that vaccines won’t work against it, say UK health experts
-
RFK Jr. vaccine panel advises restricting MMRV shot
Speed Read The committee voted to restrict access to a childhood vaccine against chickenpox
-
Texas declares end to measles outbreak
Speed Read The vaccine-preventable disease is still spreading in neighboring states, Mexico and Canada
-
RFK Jr. shuts down mRNA vaccine funding at agency
Speed Read The decision canceled or modified 22 projects, primarily for work on vaccines and therapeutics for respiratory viruses
-
Measles cases surge to 33-year high
Speed Read The infection was declared eliminated from the US in 2000 but has seen a resurgence amid vaccine hesitancy
-
Kennedy's vaccine panel signals skepticism, change
Speed Read RFK Jr.'s new vaccine advisory board intends to make changes to the decades-old US immunization system
-
Kennedy ousts entire CDC vaccine advisory panel
speed read Health Secretary RFK Jr. is a longtime anti-vaccine activist who has criticized the panel of experts